Table 2. Comparative pre and post treatment EORTC QLQ C-30 Quality of Life scores in cervical cancer women.
EORTC QLQ C-30Scale | PreTreatment | PostTreatment | P-Value* |
Global Health Status/Qol scale | |||
Global Health Status/Qol | 54.32(9.65) | 77.90(7.17) | |
Functional Scale | |||
Physical functioning | 69.86(10.73) | 80.60(27.06) | |
Role Functioning | 69.06(16.68) | 80.37(15.16) | |
Emotional Functioning | 60.20(16.37) | 77.13(14.15) | |
Cognitive Functioning | 71.06(16.68) | 73.39(18.36) | |
Social Functioning | 60.67(11.57) | 68.26(16.78) | |
Symptom scales/Items | |||
Fatigue | 38.21(11.15) | 24.88(7.32) | |
Nausea and Vomiting | 12.01(11.30) | 2.00(5.52) | |
Pain | 19.67(18.32) | 22.66(6.23) | |
Single Item scales | |||
Dyspnoea | 26.52(21.51) | 10.56(15.86) | |
Insomnia | 29.67(18.84) | 22.30(24.12) | |
Appetite loss | 33.98(17.67) | 31.20(8.36) | |
Constipation | 33.43(20.60) | 25.87(10.04) | |
Diarrhoea1 | 3.87(9.67) | 8.67(12.25) | |
Financial Difficulties | 34.67(28.62) | 46.34(19.71) |
*P values are comparisons between groups with or student’s test.
Higher scores in the functioning and global health status scales represented better functioning and QOL, whereas higher scores in the symptom scales indicated greater problems.